Renovascular disease laboratory findings

	Renovascular disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Renovascular disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Renovascular disease laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Renovascular disease laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Renovascular disease laboratory findings
CDC on Renovascular disease laboratory findings
Renovascular disease laboratory findings in the news
Blogs on Renovascular disease laboratory findings
Directions to Hospitals Treating Renovascular disease
Risk calculators and risk factors for Renovascular disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

“

CLASS III

Selective renal vein measurements are not recommended as a useful screening test to establish the diagnosis of RAS; Level of eveidence: B
The plasma renin activity is not recommended as a useful screening test to establish the diagnosis of RAS; Level of eveidence: B
The captopril test (measurements of plasma renin activity following captopril administration) is not recommended as a useful screening test to establish the diagnosis of renal artery stenosis; Level of eveidence: B

”